Recent Finacing
Recent Raise
Pharmalink is a Stockholm-based specialty pharmaceutical company developing Nefecon for primary IgA nephropathy and Busulipo as an HSCT conditioning agent, preparing pivotal trials and pursuing partnerships.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors